Advances in systemic antifungal therapy : Systemic MycosesSTEVENS, David A.Clinics in dermatology. 2012, Vol 30, Num 6, pp 657-661, issn 0738-081X, 5 p.Article

Managing fungal infections in the 21st century: focus on itraconazole: a seminar-in-printSTEVENS, David A.Drugs (Basel). 2001, Vol 61, issn 0012-6667, 61 p., SUP1Serial Issue

Role of oral amphotericin B in the management of oral candidiasisSTEVENS, David A.Journal de mycologie médicale. Supplément. 1996, Vol 6, Num 2, issn 1166-7680, 51 p.Serial Issue

An overview of fungal infectionsGARBER, Gary.Drugs (Basel). 2001, Vol 61, pp 1-12, issn 0012-6667, SUP1Article

Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatusCHOI, Jung-Hyun; BRUMMER, Elmer; STEVENS, David A et al.Microbes and infection. 2004, Vol 6, Num 4, pp 383-389, issn 1286-4579, 7 p.Article

Efficacy of ravuconazole in treatment of mucosal candidosis in SCID miceCLEMONS, Karl V; STEVENS, David A.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 12, pp 3433-3436, issn 0066-4804Article

The cost of treating systemic fungal infectionsVAN GOOL, Renilt.Drugs (Basel). 2001, Vol 61, pp 49-56, issn 0012-6667, SUP1Article

Clinical experience with itraconazole in systemic fungal infectionsBOOGAERTS, Marc; MAERTENS, Johan.Drugs (Basel). 2001, Vol 61, pp 39-47, issn 0012-6667, SUP1Article

Protection of peritoneal macrophages by granulocyte/macrophage colony-stimulating factor (GM-CSF) against dexamethasone suppression of killing of Aspergillus, and the effect of human GM-CSFBRUMMER, Elmer; MAQBOOL, Anjum; STEVENS, David A et al.Microbes and infection. 2002, Vol 4, Num 2, pp 133-138, issn 1286-4579Article

Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapyCLEMONS, Karl V; STEVENS, David A.Seminars in respiratory infections. 2001, Vol 16, Num 1, pp 60-66, issn 0882-0546Article

Comparative efficacies of four amphotericin B formulations-fungizone, amphotec (amphocil), AmBisome, and abelcet-against systemic murine aspergillosisCLEMONS, Karl V; STEVENS, David A.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 3, pp 1047-1050, issn 0066-4804, 4 p.Article

CaspofunginDERESINSKI, Stanley C; STEVENS, David A.Clinical infectious diseases. 2003, Vol 36, Num 11, pp 1445-1457, issn 1058-4838, 13 p.Article

Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosisCLEMONS, Karl V; STEVENS, David A.Journal of antimicrobial chemotherapy (Print). 2001, Vol 47, Num 2, pp 183-186, issn 0305-7453Article

Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell functionGANER, Ari; BRUMMER, Elmer; STEVENS, David A et al.Infection and immunity. 2000, Vol 68, Num 12, pp 6833-6839, issn 0019-9567Article

Paradoxical effect of caspofungin: Reduced activity against Candida albicans at high drug concentrationsSTEVENS, David A; ESPIRITU, Marife; PARMAR, Rachana et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 9, pp 3407-3411, issn 0066-4804, 5 p.Article

Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicityFACCI, Laura; STEVENS, David A; SKAPER, Stephen D et al.Neuroreport (Oxford). 2003, Vol 14, Num 11, pp 1467-1470, issn 0959-4965, 4 p.Article

Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidiaBRUMMER, Elmer; KAMBERI, Marika; STEVENS, David A et al.The Journal of infectious diseases. 2003, Vol 187, Num 4, pp 705-709, issn 0022-1899, 5 p.Article

Pharmacology of itraconazoleDE BEULE, Karel; VAN GESTEL, Jef.Drugs (Basel). 2001, Vol 61, pp 27-37, issn 0012-6667, SUP1Article

Review of newer antifungal and immunomodulatory strategies for invasive aspergillosisSTEINBILCH, William J; STEVENS, David A.Clinical infectious diseases. 2003, Vol 37, pp S157-S187, issn 1058-4838, SUP3Article

Diagnosing invasive fungal disease in critically ill patientsHSU, Joe L; RUOSS, Stephen J; BOWER, Natalie D et al.Critical reviews in microbiology. 2011, Vol 37, Num 4, pp 277-312, issn 1040-841X, 36 p.Article

Hormones and the Resistance of Women to ParacoccidioidomycosisSHANKAR, Jata; RESTREPO, Angela; CLEMONS, Karl V et al.Clinical microbiology reviews (Print). 2011, Vol 24, Num 2, issn 0893-8512, 226, 296-313 [19 p.]Article

Effect of 3M-003, an imidazoquinoline, on phagocyte candidacidal activity directly and via induction of peripheral blood mononuclear cell cytokinesBRUMMER, Elmer; ANTONYSAMY, Mary A; BYTHADKA, Lakshmi et al.FEMS immunology and medical microbiology (Print). 2010, Vol 59, Num 1, pp 81-89, issn 0928-8244, 9 p.Article

A New Method for the Treatment of Chronic Fungal Meningitis: Continuous Infusion into the Cerebrospinal Fluid for Coccidioidal MeningitisBERRY, Carol D; STEVENS, David A; HASSID, Eric I et al.The American journal of the medical sciences (Print). 2009, Vol 338, Num 1, pp 79-82, issn 0002-9629, 4 p.Article

Significant differences in drug susceptibility among species in the Candida parapsilosis groupVAN ASBECK, Eveline; CLEMONS, Karl V; MARTINEZ, Marife et al.Diagnostic microbiology and infectious disease. 2008, Vol 62, Num 1, pp 106-109, issn 0732-8893, 4 p.Article

Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy : An Externally Controlled TrialWALSH, Thomas J; RAAD, Issam; LANGSTON, Amelia et al.Clinical infectious diseases. 2007, Vol 44, Num 1, pp 2-12, issn 1058-4838, 11 p.Article